A detailed history of Nebula Research & Development LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 51,924 shares of TNGX stock, worth $89,828. This represents 0.02% of its overall portfolio holdings.

Number of Shares
51,924
Previous 10,901 376.32%
Holding current value
$89,828
Previous $83.9 Million 91.15%
% of portfolio
0.02%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$2.79 - $7.46 $114,454 - $306,031
41,023 Added 376.32%
51,924 $160 Million
Q3 2024

Nov 14, 2024

BUY
$7.36 - $11.93 $80,231 - $130,048
10,901 New
10,901 $83.9 Million

Others Institutions Holding TNGX

About Tango Therapeutics, Inc.


  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $152M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.